Presentation by Avella Specialty Pharmacy & mScripts at Armada 2015 on improving medication adherence through mobile app technology. Learn about how Avella meets the challenges of medication non-adherence: http://www.avella.com/medication-adherence
Team Lift: Predicting Medication AdherenceNeil Ryan
Medication adherence is a growing public health concern in the US. It is the extent to which patients are taking medications as prescribed by their healthcare providers. Simply put, are patients eating their pills on time?
We looked at patient data from Medicare part D program released by Centers for Medicare & Medicaid services. We built a prediction model to ascertain whether a patient would be adherent based on a variety of social, economic and behavioral aspects.
Rebecca M. Shanahan, CEO of Avella Specialty Pharmacy presents on Specialty Pharmacy at Retail Pharmacy at the 2014 Armada Summit. Learn more about Avella and connect with your local rep if you have any questions. http://www.avella.com/
Team Lift: Predicting Medication AdherenceNeil Ryan
Medication adherence is a growing public health concern in the US. It is the extent to which patients are taking medications as prescribed by their healthcare providers. Simply put, are patients eating their pills on time?
We looked at patient data from Medicare part D program released by Centers for Medicare & Medicaid services. We built a prediction model to ascertain whether a patient would be adherent based on a variety of social, economic and behavioral aspects.
Rebecca M. Shanahan, CEO of Avella Specialty Pharmacy presents on Specialty Pharmacy at Retail Pharmacy at the 2014 Armada Summit. Learn more about Avella and connect with your local rep if you have any questions. http://www.avella.com/
Donors such as the Bill & Melinda Gates Foundation, USAID and Global Affairs Canada are supporting the TB REACH Wave 6 initiative to fund innovation and research to (i) improve detection, linkage to treatment and reporting of TB, and (ii) improve TB treatment adherence and outcomes. Last week, I helped launch the Wave 6 call, presenting an overview of TB adherence technologies and highlighting areas of interest and focus for Wave 6 applicants. To find out more, visit: http://www.stoptb.org/global/awards/tbreach/wave6.asp
Identifying & Overcoming Gaps in the Specialty-Pharmacy EcosystemCognizant
Specialty drug expenditures in the U.S. are rising dramatically, compelling manufacturers to accelerate the turnaround time from patient enrollment to drug disbursement. Using data analytics tools, these companies can track patients throughout their treatment and ensure continuous patient therapy.
Medication non-adherence is a growing concern, as it is increasingly associated with negative health outcomes and higher cost of care. Tackling the burden of non-adherence requires a collaborative, patient-centric approach that considers individual patient needs and results in intelligent interventions that combine high-tech with high-touch.
Stop TB Partnership focus group session 10-20-17Bruce Thomas
The Arcady Group founder, Bruce Thomas, led the Stop TB Partnership's Focus Group Workshop On Digital Adherence Technologies. At this meeting, innovators such as Everwell Health (99DOTS), Wisepill Technologies (evriMED medication monitor), Keheala (SMS-based behavioral counseling) and SureAdhere Mobile Technology (V-DOT) were connected with representatives of key NGO implementers and country programs (including Zimbabwe, Philippines, Moldova, and South Africa) to discuss opportunities for experimentation and uptake of digital adherence technologies through TB REACH Wave 6 grants. Bruce and Ram Subbaraman shared new evidence and insights about the importance of treatment adherence to avoid TB relapse.
3 Pharmacy Trends You Should Know for 2015weatrust
WEA Trust’s new Director of Clinical Pharmacy, Alan Lukazewski, will share his pharmacy forecast for the upcoming year. Learn about the phenomenon of generic drug inflation, how expensive brand drugs will change formularies, and the cost imperative to proper medication usage.
Lukazewski has over 30 years of industry experience, from long term care consulting to retail pharmacy. His mission is to deliver a sustainable, high-quality pharmacy benefit along with a highly responsive, personalized customer service experience.
BRP Pharmaceuticals is a leader in physician dispensing services that provides instant medication to patients located in Burbank, CA. Visit: http://www.brppharma.com/
SVMPharma Real World Evidence - Randomised controlled trials were never desig...SVMPharma Limited
SVMPharma Real World Evidence - Conventional RCTs are necessary for determining efficacy and safety, but real-world clinical practice can be very different. RWE complements RCT data and offers the opportunity to bridge the data gaps.
Have you identified your data gaps? For more information and resources visit us at www.svmpharma.com
Medication Adherence is a pressing issue in the healthcare setting. New advances in technology using mobile apps and smart devices are now changing the way we approach assessing patients medication adherence. However, this shift also allows a new chance to be engaged with patients regarding their medications and offers the opportunity to be more aware of medication related issues.
Genetic Testing Reduces Specialty Drug SpendWellDyne
An award-winning WellDyneRx study, recognized by the Academy of Managed Care Pharmacy, found that pharmacogenomics screening saved self-funded employers 5 percent in specialty drug claim costs.
A Better Way To Remember: Using Mobile Technology to Improve HIV Medication A...YTH
A better way to remember: Using mobile phones to improve HIV medication adherence and promote regular HIV testing in Oregon. Reaching out to MSM, gay men, IDU, and everyone who could use an SMS, email or voice reminder.
Donors such as the Bill & Melinda Gates Foundation, USAID and Global Affairs Canada are supporting the TB REACH Wave 6 initiative to fund innovation and research to (i) improve detection, linkage to treatment and reporting of TB, and (ii) improve TB treatment adherence and outcomes. Last week, I helped launch the Wave 6 call, presenting an overview of TB adherence technologies and highlighting areas of interest and focus for Wave 6 applicants. To find out more, visit: http://www.stoptb.org/global/awards/tbreach/wave6.asp
Identifying & Overcoming Gaps in the Specialty-Pharmacy EcosystemCognizant
Specialty drug expenditures in the U.S. are rising dramatically, compelling manufacturers to accelerate the turnaround time from patient enrollment to drug disbursement. Using data analytics tools, these companies can track patients throughout their treatment and ensure continuous patient therapy.
Medication non-adherence is a growing concern, as it is increasingly associated with negative health outcomes and higher cost of care. Tackling the burden of non-adherence requires a collaborative, patient-centric approach that considers individual patient needs and results in intelligent interventions that combine high-tech with high-touch.
Stop TB Partnership focus group session 10-20-17Bruce Thomas
The Arcady Group founder, Bruce Thomas, led the Stop TB Partnership's Focus Group Workshop On Digital Adherence Technologies. At this meeting, innovators such as Everwell Health (99DOTS), Wisepill Technologies (evriMED medication monitor), Keheala (SMS-based behavioral counseling) and SureAdhere Mobile Technology (V-DOT) were connected with representatives of key NGO implementers and country programs (including Zimbabwe, Philippines, Moldova, and South Africa) to discuss opportunities for experimentation and uptake of digital adherence technologies through TB REACH Wave 6 grants. Bruce and Ram Subbaraman shared new evidence and insights about the importance of treatment adherence to avoid TB relapse.
3 Pharmacy Trends You Should Know for 2015weatrust
WEA Trust’s new Director of Clinical Pharmacy, Alan Lukazewski, will share his pharmacy forecast for the upcoming year. Learn about the phenomenon of generic drug inflation, how expensive brand drugs will change formularies, and the cost imperative to proper medication usage.
Lukazewski has over 30 years of industry experience, from long term care consulting to retail pharmacy. His mission is to deliver a sustainable, high-quality pharmacy benefit along with a highly responsive, personalized customer service experience.
BRP Pharmaceuticals is a leader in physician dispensing services that provides instant medication to patients located in Burbank, CA. Visit: http://www.brppharma.com/
SVMPharma Real World Evidence - Randomised controlled trials were never desig...SVMPharma Limited
SVMPharma Real World Evidence - Conventional RCTs are necessary for determining efficacy and safety, but real-world clinical practice can be very different. RWE complements RCT data and offers the opportunity to bridge the data gaps.
Have you identified your data gaps? For more information and resources visit us at www.svmpharma.com
Medication Adherence is a pressing issue in the healthcare setting. New advances in technology using mobile apps and smart devices are now changing the way we approach assessing patients medication adherence. However, this shift also allows a new chance to be engaged with patients regarding their medications and offers the opportunity to be more aware of medication related issues.
Genetic Testing Reduces Specialty Drug SpendWellDyne
An award-winning WellDyneRx study, recognized by the Academy of Managed Care Pharmacy, found that pharmacogenomics screening saved self-funded employers 5 percent in specialty drug claim costs.
A Better Way To Remember: Using Mobile Technology to Improve HIV Medication A...YTH
A better way to remember: Using mobile phones to improve HIV medication adherence and promote regular HIV testing in Oregon. Reaching out to MSM, gay men, IDU, and everyone who could use an SMS, email or voice reminder.
PrEP Update from the International HIV Treatment, Prevention, and Adherence C...Office of HIV Planning
Jen Chapman, Co-Chair of the Philadelphia HIV Prevention Planning Group (HPG) presented an update from the 10th annual International HIV Treatment, Prevention, and Adherence conference at the July 2015 HPG meeting.
ВИЧ-инфекция у женщин : стратегии 3 ключевых глобальных проблем.2016.HIV In...hivlifeinfo
ВИЧ-инфекция у женщин : стратегии 3 ключевых глобальных проблем.2016.HIV Infection Among Women- Strategies to Address 3 Key Global Challenges .2016
In this downloadable slideset, Catherine Hankins, MD, PhD, FRCPC, CM, reviews current global challenges for HIV-infected women and explores methods for HIV prevention and ART delivery, particularly in resource-limited settings.
Format: Microsoft PowerPoint (.ppt)
File size: 1.03 MB
Date posted: 9/1/2016
In this downloadable slideset, expert faculty members Andrew Carr, MBBS, MD, FRACP, FRCPA; Daniel R. Kuritzkes, MD; and Ian M. Sanne, MBBCH, FCP(SA), review key studies presented at the 2016 International AIDS Conference.
Format: Microsoft PowerPoint (.ppt)
File size: 1.28 MB
Date posted: 8/5/2016
Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...Efe Clement Abel
Abstract: Adherence is the quantified level to which an individual follows a prescribed treatment and a low level of adherence to antiretroviral therapy(ART) adversely affects a patient’s treatment outcome and results in a rebound of plasma viraemia, development of resistant strains of HIV, more rapid immune deterioration, development of AIDS and death. This study is aimed at assessing the level of adherence to ART among HIV-positive patients assessing care in Central Hospital, Warri, Delta State, Nigeria. A descriptive cross-sectional study. Data were obtained using a semi-structured, interviewer-administered questionnaire and analysed using SPSS version 23. A total of 303 persons were recruited for the study. The mean age of respondents was 36.2±10.8years. Less than half of the subjects (45.5%) were adherent to their ART. Among the non-adherent subjects, the common reasons reported for missing doses of ART were forgetfulness (50.9%), too busy with other things (43.6%) and away from home (35.8%). This study showed that adherence to ART among the study population was poor. Forgetfulness, too busy with other things and being away from home were the most common reason for non-adherence. It is, therefore, recommended that; regular health education should be organised for HIV patients on ART on the importance of being adherent to their ART, regular assessment of adherence to ART should be carried out and a method of reminding patients who are non-adherent to ART on the need to take their ART as at when due should be considered as part of the routine services provided by ART centres.
How general internists can participate in the continuum of care for patients with cancer. (Talk given at Internal Medicine Grand Rounds, St. Elizabeth Hospital, General Santos City, 10 Feb 2021.)
Evaluation of Anti-Retroviral Combination Therapy In Patients With HIV/Aids I...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...John Blue
Antimicrobial Use and Stewardship in the Pediatric Outpatient Setting - Dr. Theoklis Zaoutis, Chief, Division of Infectious Diseases, Professor of Pediatrics and Epidemiology of the University of Pennsylvania, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...Hivlife Info
Доктор David A. Wohl при участии группы экспертов, рассматривает основные исследования о том, когда и как, при каких условиях переводить пациентов со стабильной супрессией ВИЧ на новые методы лечения .
Similar to Improving HIV Medication Adherence Using Mobile Health Technology (20)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The Impact of Meeting: How It Can Change Your Life
Improving HIV Medication Adherence Using Mobile Health Technology
1. IMPROVING HIV MEDICATION ADHERENCE
USING MOBILE HEALTH TECHNOLOGY
Fiona Smythe I mscripts
Eric Sredzinski, Pharm.D, AAHIVP I Avella Specialty Pharmacy
2. 2
PERCENT OF RETAIL PRESCRIPTIONS ABANDONED,
REJECTED AND REASONS FOR REJECTIONS, 2013
DISTRIBUTION OF PAYER REJECTION
REASONS IN SELECTED CLASSES
Almost 10% of the 3.6 billion retail prescriptions
written by physicians are NOT dispensed to patients
PrescriptionAbandonment and Payer Rejections
3. 3
• Patient Characteristics
• Health beliefs
• Quality of life/Health status
• Understanding of disease/Therapy
• Psychological state
• Social support
• SES status
• Forgetfulness and lifestyle factors
• Disease characteristics
PREDISPOSING FACTORS
• Complexity of regimen
• Food interaction
• Side Effects of regimen
• Schedule of regimen
• Cost of drug
• Cost of side-effects of treatment
• Cost of follow-up care
TREATMENT FACTORS
POSSIBLE INTERVENTIONS POSSIBLE INTERVENTIONS
Fig 1. Schematic of factors and barriers involved in adherence to targeted OAMs and possible ways to improve adherence.
ADHERENCE
&
PERSISTENCE
• Identify degree of adherence
• Use assessment tools
• Ask about barriers
• Keep an open non-confrontational dialogue
• Increase patient education at every visit
• Provide literature on side effects
• Refer to support groups, websites, and
disease specific organizations
• Involve physicians, nurses, pharmacists and
family members
• Multi-disciplinary approach
• The patient has a “team”
• Address Costs
• Use available assistance programs
• Help patients apply for necessary benefits
• Make sure refills are ordered in time
• Consider initiating nurse-led phone calls to
assess adherence, side-effects and any barriers
• Encourage tools to help with adherence
• Pill boxes, alarms, calendars, daily routines
SYSTEM FACTORS
• Interaction with M.D.
• Interaction with nurse
• Ease of drugs
• Satisfaction with care
Barriers toAdherence
4. 4
Cochrane Review, Oct, 2005;
Transplantation (2007;83:858-873)
Blood (2007;109:58-60)
Disease
Rates of non-
adherence
Epilepsy 30% to 50%
Arthritis 50% to 71%
Hypertension 40% (average)
Diabetes 40% to 50%
Oral
Contraceptives
8%
HRT 57%
Asthma 20%
Kidney Transplant 35.6%
Heart Transplant 14.5%
Liver Transplant 6.7%
CML (Imatinib) 25%
COMPLIANCE DECLINES WITH TIME
BenchmarkAdherence Rates
5. 5
Study population size Rates of adherence
N=17,573 patients from 33 studies 55% adherent
N=540 patients from 1 cohort 32.78% adherent
N=3,140 patients from 22 US studies 53%
Adherence defined as- 85-100% MPR or
viral suppression of <50 - <500 copies/ml
N=862 ART naïve patients 36% discontinued therapy
ARVAdherence
6. 6
Adapted from Maggiolo et al. Clin Infect Dis. 2005;40:158-63.
NNRTI = nonnucleoside reverse transcriptase inhibitor;
PI = protease inhibitor.
Relation BetweenAdherence and Treatment Failure
7. 7
$1.8 Billion
HIV
$105.4 BILLION TOTAL
AVOIDABLE COSTS BY DISEASE
IMS Institute for Healthcare Informatics, 2013
$44 Billion
Hypercholesterolemia
$24.6 Billion
Diabetes
$18.6 Billion
Hypertension
$15.5 Billion
Osteoporosis
$1 Billion
Congestive heart failure
HIV Cost of Non-Adherence
12. 12
Timely two-way
messaging
Create an experience
that is intuitive, easy to
use and adds value for
patients
Real-time notifications
provide behavioral
“nudges”
Build on existing habits
• Reinforce good behavior
• Small, incremental modifications
Customized messaging
based on behavior
Stringent privacy practices
• Double-opt in text registration
• Data masking
Employing Best Practices
13. 13
Pharmacy
Management
System
Patient Portal
Mobile Pharmacy
App
360 visibility into patient data
Integrations between the dispensing system,
patient portals and mobile pharmacy apps
Real-time data provides insight into behavior
Understand risk and design interventions with
predictive analytics
mHealth Strategies in Specialty Pharmacy
14. 14
To
open: hold down tab &
tu
rn
Get
our mobile a
pp:
av
ella.com/ap
p
E-mails
avella.com on mobile
Pill bottles
Fax
In-store display
Print
Rollout Strategy: Marketing Touch Points
15. 15
PRIMARY
OBJECTIVES
• Proving efficacy of mobile to increase adherence
• Decreasing operational burden
• Validating systems integration
BARRIERS
• High consumer expectations set by retail apps
• HIPAA/HITECH, TCPA
• Strong feelings of “What’s in it for me” require intensive patient education
• Getting app onto patient’s phone & getting them to use it
ASSUMPTIONS • Multi-faceted program using mobile health
• Impact of mobile-optimized adherence tools
• Replicable for other hard-to-manage populations
AClinical Study Tests TheseAssumptions
16. 16
• On- and off-platform cohorts
• Brand name ARVs of interest
• Retrospective cohort PDC and survival analysis
Atripla, Complera, Intelence, Isentress, Kaletra,
Norvir, Reyataz, Stribild, Trizivir, Truvada
On-platform = 224 (10.6%)
Off-platform/control = 1,896 (89.4%)
• Study period of 12 months
• Possible self-selection bias
Methodology
19. 19
< 1 year
(97%)
>1 year
(3%)
TIME SINCE PLATFORM REGISTRATION
Turned
on 221
(99%)
Turned
off 3 (1%)
REFILL REMINDER PREFERENCE
Measurements of Success:
Platform Engagement
20. 20
Zero 0
(0%)
One 11
(5%)
Two 173
(78%)
Three 37
(17%)
NUMBER OF ACTIVE
NOTIFICATION METHODS
None 0%
In-app
notification
47%Text
Message
43%
Email 10%
NOTIFICATION METHOD PREFERENCE
Measurements of Success:
Platform Engagement
24. 24
OPPORTUNITIES TO OPTIMIZE
ADHERENCE TOOLS THROUGH
MOBILE HEALTH
• Peer support forums
• Feedback through surveys
• Adverse event reporting
• Financial assistance based on perceived need
• Secure messaging, chat, or video
• Delivery of educational material
• Clinical trials – Researchkit
• Interfacing with EMR or patient portals
• Patient ownership and control of data
• Predictive analytics and interventions
Source: Fierce Mobile Healthcare
APPS WILL BECOME MORE
DISEASE SPECIFIC
• Deliver relevant information
based on condition and behavior
Continuous Improvement:
The Road Ahead for Mobile Adherence